News

ascopubs.org6d
Dissecting primary endocrine resistance through ctDNA profiling of a hybrid real-world and clinical trial dataset in hormone receptor-positive, HER2-negative (HR+/HER2 ...
Differences in genomic profiles, targeted treatment use, and overall survival in patients with metastatic breast cancer by Area Deprivation Index. This is an ASCO Meeting Abstract from the 2025 ASCO ...
ascopubs.org6d
Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic nasal cavity and paranasal sinus squamous-cell carcinoma: A ...
Real world utilization of comprehensive genomic profiling (CGP) in head and neck squamous cell carcinoma (SCCHN). This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...